Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double‐blind, 8‐week study
The journal of clinical hypertension (Greenwich, Conn.), 2019-01, Vol.21 (1), p.67-76 [Peer Reviewed Journal]2018 Wiley Periodicals, Inc. ;ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/jch.13437 ;PMID: 30536595
Full text available